These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 38530263)

  • 1. Clinical Guidelines on Nonalcoholic Fatty Liver Disease-Reply.
    Leung PB; Davis AM; Kumar S
    JAMA; 2024 Mar; 331(12):1063-1064. PubMed ID: 38530263
    [No Abstract]   [Full Text] [Related]  

  • 2. A REVIEW OF INTERNATIONAL AND NATIONAL CLINICAL GUIDELINES FOR THE DIAGNOSIS AND TREATMENT-OF NONALCOHOLIC FATTY LIVER DISEASE.
    Golovanova EV; Lazebnik LB
    Eksp Klin Gastroenterol; 2016; (11):76-83. PubMed ID: 29889450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis and Management of Nonalcoholic Fatty Liver Disease.
    Paul S; Davis AM
    JAMA; 2018 Dec; 320(23):2474-2475. PubMed ID: 30476962
    [No Abstract]   [Full Text] [Related]  

  • 4. Guidelines of prevention and treatment of nonalcoholic fatty liver disease (2018, China).
    Fan JG; Wei L; Zhuang H;
    J Dig Dis; 2019 Apr; 20(4):163-173. PubMed ID: 30444584
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical Guidelines on Nonalcoholic Fatty Liver Disease.
    Spacek L
    JAMA; 2024 Mar; 331(12):1062-1063. PubMed ID: 38530265
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical Guidelines on Nonalcoholic Fatty Liver Disease.
    Braillon A
    JAMA; 2024 Mar; 331(12):1063. PubMed ID: 38530266
    [No Abstract]   [Full Text] [Related]  

  • 7. [An interpretation of European guidelines for the diagnosis and treatment of nonalcoholic fatty liver disease].
    Xin FZ; Fan JG
    Zhonghua Gan Zang Bing Za Zhi; 2016 Jun; 24(6):403-5. PubMed ID: 27465941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences between current clinical guidelines for screening, diagnosis and management of nonalcoholic fatty liver disease and real-world practice: a targeted literature review.
    Schattenberg JM; Anstee QM; Caussy C; Bugianesi E; Popovic B
    Expert Rev Gastroenterol Hepatol; 2021 Nov; 15(11):1253-1266. PubMed ID: 34493137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. KASL clinical practice guidelines: Management of nonalcoholic fatty liver disease.
    Kang SH; Lee HW; Yoo JJ; Cho Y; Kim SU; Lee TH; Jang BK; Kim SG; Ahn SB; Kim H; Jun DW; Choi JI; Song DS; Kim W; Jeong SW; Kim MY; Koh H; Jeong S; Lee JW; Cho YK;
    Clin Mol Hepatol; 2021 Jul; 27(3):363-401. PubMed ID: 34154309
    [No Abstract]   [Full Text] [Related]  

  • 10. Diagnosis and Management of Nonalcoholic Fatty Liver Disease.
    Leung PB; Davis AM; Kumar S
    JAMA; 2023 Nov; 330(17):1687-1688. PubMed ID: 37843854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-alcoholic fatty liver disease (NAFLD): summary of NICE guidance.
    Glen J; Floros L; Day C; Pryke R;
    BMJ; 2016 Sep; 354():i4428. PubMed ID: 27605111
    [No Abstract]   [Full Text] [Related]  

  • 12. Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: Implications for liver transplantation.
    Younossi ZM
    Liver Transpl; 2018 Feb; 24(2):166-170. PubMed ID: 29272073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NONALCOHOLIC FATTY LIVER DISEASE BRAZILIAN SOCIETY OF HEPATOLOGY CONSENSUS.
    Cotrim HP; Parise ER; Figueiredo-Mendes C; Galizzi-Filho J; Porta G; Oliveira CP
    Arq Gastroenterol; 2016; 53(2):118-22. PubMed ID: 27305420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis 2020.
    Tokushige K; Ikejima K; Ono M; Eguchi Y; Kamada Y; Itoh Y; Akuta N; Yoneda M; Iwasa M; Yoneda M; Otsuka M; Tamaki N; Kogiso T; Miwa H; Chayama K; Enomoto N; Shimosegawa T; Takehara T; Koike K
    J Gastroenterol; 2021 Nov; 56(11):951-963. PubMed ID: 34533632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [NONALCOHOLIC FATTY LIVER DISEASE: DIAGNOSTIC, SYMPTOMS, TREATMENT. GUIDELINES WERE APPROVED BY THE XV GASTROENTEROLOGICAL SCIENTIFIC SOCIETY OF RUSSIA IN 2015].
    Lazebnik LB; Radchenko VG; Golovanova EV; Zvenigorodskaya LA; Konev YV; Seliverstov PV; Sitkin SI; Tkachenko EI; Aylamazayn EK; Vlasov NN; Kornienko EA; Novikova VP; Horoshinina LP; Zhestkova NV; Oreshko LS; Dudanova OP; Dobrica VP; Turyeva LV; Tirikova OV; Kozlova NM; Eliseev SM; Gumerov RR; Vencak EV
    Eksp Klin Gastroenterol; 2015; (7):85-96. PubMed ID: 26817127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonalcoholic Fatty Liver Disease: Diagnosis and Management Guidelines From the AACE.
    Arnold MJ
    Am Fam Physician; 2023 May; 107(5):554-556. PubMed ID: 37192061
    [No Abstract]   [Full Text] [Related]  

  • 17. Transaminases and Pediatric Nonalcoholic Fatty Liver Disease Diagnosis.
    Vajro P
    J Pediatr Gastroenterol Nutr; 2017 Nov; 65(5):e114. PubMed ID: 29064931
    [No Abstract]   [Full Text] [Related]  

  • 18. [An interpretation of the AASLD practice guideline on the diagnosis and management of nonalcoholic fatty liver disease in 2017].
    Nan YM; Fu N; Li WC; Kong LL; Yuan XW; Zhang SY; Liu LD; Lu Y; Cui LY
    Zhonghua Gan Zang Bing Za Zhi; 2017 Sep; 25(9):687-694. PubMed ID: 29108191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases.
    Chalasani N; Younossi Z; Lavine JE; Charlton M; Cusi K; Rinella M; Harrison SA; Brunt EM; Sanyal AJ
    Hepatology; 2018 Jan; 67(1):328-357. PubMed ID: 28714183
    [No Abstract]   [Full Text] [Related]  

  • 20. EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease.
    ; ;
    J Hepatol; 2016 Jun; 64(6):1388-402. PubMed ID: 27062661
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.